sio Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Search past issues
Search products and services

In November 2016, the Society of Interventional Oncology formally commissioned a white paper to explore the synergies between IO and immuno-oncology. A panel of 18 expert interventional oncologists...

source: SIO

Did you know that bundling membership to the Society of Interventional Oncology (SIO) with SIO 2019 registration...


High expression of vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma (HCC) is associated with poor prognosis. We investigated the antitumor activity...

source: Cancer Investigation

The incidence and overall mortality of hepatocellular carcinoma (HCC) in the U.S. have been increasing over the past decade. Venous thromboembolism (VTE) is a leading cause of morbidity and mortality in...

source: Journal of Gastrointestinal Cancer

Cyclin‐dependent kinases (CDKs) are a family of twenty‐one different protein kinases involved in regulating cell proliferation, apoptosis and drug resistance, and are evaluated in preclinical...

source: Hepatology Research

In their manuscript, ‘Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer’, Basak et al. hypothesise that patients who were treated with nivolumab and exhibited...

source: European Journal of Cancer


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to IO Insights

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of SIO? Yes   No
Privacy Policy